Sorafenib hæmmer tumorvækst i et bredt spektrum af humant tumorvæv implanteret i mus uden tymus fulgt af en reduktion af tumorangiogenese.
Sorafenib inhibits tumour growth of a broad spectrum of human tumour xenografts in athymic mice accompanied by a reduction of tumour angiogenesis.